{"result": "(\"entity\"<|>EUROPEAN SOCIETY OF CLINICAL NUTRITION AND METABOLISM<|>ORGANIZATION<|>The European Society of Clinical Nutrition and Metabolism (ESPEN) provides guidelines on nutrition for various patient groups, including those with cancer and dementia.)\n##\n(\"entity\"<|>CANCER<|>EVENT<|>Cancer is a disease characterized by uncontrolled cell growth, which can lead to various health complications and requires specific nutritional considerations.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPLEMENTATION<|>EVENT<|>Nutritional supplementation refers to the process of providing additional nutrients to patients, particularly those with specific health conditions like cancer or dementia.)\n##\n(\"entity\"<|>VITAMIN C<|>PERSON<|>Vitamin C is a nutrient that is often discussed in the context of dietary recommendations for cancer patients, though its high doses are debated.)\n##\n(\"entity\"<|>VITAMIN E<|>PERSON<|>Vitamin E is a nutrient that is often considered in the dietary management of cancer patients, with mixed evidence regarding its benefits.)\n##\n(\"entity\"<|>SELENIUM<|>PERSON<|>Selenium is a micronutrient that is sometimes included in discussions about dietary supplementation for cancer patients.)\n##\n(\"entity\"<|>BETACAROTENE<|>PERSON<|>Betacarotene is a precursor to vitamin A and has been studied for its effects on cancer patients, with some studies indicating potential risks associated with high intake.)\n##\n(\"entity\"<|>SHORT BOWEL SYNDROME<|>EVENT<|>Short bowel syndrome (SIC) is a condition that can arise after surgical removal of a significant portion of the intestine, leading to nutritional deficiencies and complications.)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY OF CLINICAL NUTRITION AND METABOLISM<|>CANCER<|>ESPEN provides guidelines on nutrition specifically for cancer patients, addressing their unique dietary needs<|>8)\n##\n(\"relationship\"<|>CANCER<|>NUTRITIONAL SUPPLEMENTATION<|>Nutritional supplementation is often considered for cancer patients to address deficiencies and support treatment<|>7)\n##\n(\"relationship\"<|>VITAMIN C<|>CANCER<|>Vitamin C is discussed in the context of dietary recommendations for cancer patients, particularly regarding its intake levels<|>6)\n##\n(\"relationship\"<|>VITAMIN E<|>CANCER<|>Vitamin E is often evaluated for its potential benefits and risks in cancer treatment and dietary management<|>6)\n##\n(\"relationship\"<|>SELENIUM<|>CANCER<|>Selenium is included in discussions about dietary supplementation for cancer patients, though its efficacy is debated<|>5)\n##\n(\"relationship\"<|>BETACAROTENE<|>CANCER<|>Betacarotene has been studied in relation to cancer, with findings suggesting potential risks associated with high intake<|>5)\n##\n(\"relationship\"<|>SHORT BOWEL SYNDROME<|>NUTRITIONAL SUPPLEMENTATION<|>Nutritional supplementation is critical for managing patients with short bowel syndrome to prevent deficiencies<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: sculo está alterada; por ello se pueden beneficiar de un aumento del                                                porcentaje de ganancia de peso se correlaciona positivamente con el aporte energético diario\n         aporte calórico a expensas de aumentar las grasas.                                                                                       de la suplementación. Además de ello, son bien tolerados y con nivel de adherencia bueno.\n                                                                                                                                                  Por ello, el grado de evidencia de uso de SNO en pacientes con demencia es alto.\n                                                                                                                                                  Referencias:\n                                                                                                                                                  • Volkert D, Chourdakis M, Faxen-Irving G, Frühwald T, Landi F, Suominen MH, et al. ESPEN guidelines on nutrition in dementia.\n                                                                                                                                                    Clin Nutr. 2015;34:1052-73.\n\n\n\n228                                                                                                                                                                                                                                                                            229\n---\n                                                                                                                                                                                                                                           NUTRICIÓN                            4\n\n\n\n     36  Respecto a la suplementación nutricional en pacientes oncológicos es falso que:                                                            COMENTARIO\n         A. Deben recibir una dieta que proporcione la vitamina C en cantidades RDA, sin superar                                                    La urolitiasis aparece en el 25% de pacientes con SIC y anastomosis yeyunocólicas/yeyu-\n             el doble de estas recomendaciones.                                                                                                     noileocólicas, debido a que la deficiencia de sales biliares no permite una correcta solubi-\n         B. El uso de altas dosis de antioxidantes (vitaminas A, C, E, selenio, flavonoides) está                                                   lización y absorción de los ácidos grasos, que se ligan al calcio intraluminal, el cual no se\n             recomendado, ya que confiere ventajas a las células de huésped frente a las tumorales                                                  une al oxalato para ser excretado por las heces, lo que provoca un exceso de absorción de\n             cuando se recibe el tratamiento quimioterápico.                                                                                        oxalato por la mucosa colónica.\n         C. No hay evidencia para recomendar el uso de vitamina E en pacientes que reciben                                                          Los pacientes con resecciones ileales y colon en continuidad pueden presentar diarrea con\n             radioterapia o quimioterapia.                                                                                                          prurito perianal por déficit          de reabsorción de sales biliares. Se benefician de tratamiento\n         D.  Todas las respuestas anteriores son falsas.                                                                                            con quelantes de sales biliares.\n                                                                                                                                                    La nutrición parenteral domiciliaria es el tratamiento estándar en pacientes con fallo intes-\n         COMENTARIO                                                                                                                                 tinal, y las complicaciones más importantes de este tratamiento son las infecciosas. Las\n                                                                                                                                                    complicaciones a largo plazo y su prevención se resumen en la tabla 7.\n         Según las recientes guías de la European Society of Clinical Nutrition and Metabolism\n         (ESPEN), las recomendaciones de vitaminas y minerales de los pacientes oncológicos no                                                      Tabla 7. Complicaciones a largo plazo y prevención de la nutrición parenteral domiciliaria\n         difieren de las RDA de población general, y con base en la evidencia actual no se recomien-                                                (NPD)\n         da suplementación específica en este grupo de pacientes.                                                                                                                     • Ajustar el aporte calórico evitando la sobrealimentación\n         En general, se deben evitar las dosis altas de micronutrientes en pacientes con cáncer, aun-                                                                                 • Estimular la alimentación oral\n         que su uso es extendido. Un metaanálisis de 68 estudios con más de 230.000 pacientes no                                                     Complicaciones\n         demostró ningún efecto protector en el grupo de antioxidantes; sin embargo, se detectó un                                                   hepatobiliares                   • Infundir la NPD de forma cíclica\n         aumento de mortalidad en el grupo de alta ingesta de betacaroteno, vitamina A y vitamina E.                                                                                  • Prevenir y tratar las infecciones por catéter y el sobrecrecimiento\n         Otros estudios que incluyen micronutrientes como el selenio y la vitamina C tampoco                                                                                            bacteriano\n         muestran efectos beneficiosos en la incidencia ni en la evolución de pacientes con cáncer                                                                                    • Adecuación de los niveles calcio/fósforo\n         de próstata.                                                                                                                                Complicaciones óseas             • Evitar la acidosis metabólica y la sobrecarga proteica\n         Referencias:                                                                                                                                                                 • Tratar la deficiencia de vitamina D\n         • Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr.\n           2017;36(1):11-48.\n                                                                                                                                                     Déficits/excesos de              • Individualizar las necesidades\n                                                                                                                                                     micro o macronutrientes          • Monitorizar\n     37  En cuanto a las complicaciones asociadas al síndrome de intestino corto (SIC) no es\n         cierto que:                                                                                                                                Referencias:\n                                                                                                                                                    • Higuera Pulgar I, Cuerda Compés MC. Nutrición en el SIC\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}